Cargando…
Effect of cyclic substituents on the anti-cancer activity and DNA interaction of ruthenium(II) bis-phenanthroline dipyridoquinoline
Introduction: Ruthenium(II) complexes have emerged recently as candidates for anti-cancer therapy, where activity is related to lipohilicity, cellular localization, and specific interactions with biomolecules. Methods: In this work, two novel complexes were synthesized and are reported based on the...
Autores principales: | Nyong-Bassey, Etubonesi E., Hicks, Andrew L., Bergin, Poppy, Tuite, Eimer M., Kozhevnikov, Valery, Veuger, Stephany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619691/ https://www.ncbi.nlm.nih.gov/pubmed/37920709 http://dx.doi.org/10.3389/fmolb.2023.1252285 |
Ejemplares similares
-
Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines
por: Abdelaal, Gina, et al.
Publicado: (2022) -
Tris(1,10-phenanthroline-κ(2)
N,N′)ruthenium(II) bis(perchlorate)
por: Kozlowska, Mariana, et al.
Publicado: (2012) -
Bis(2,2′-bipyridine)(5-isothiocyanato-1,10-phenanthroline)ruthenium(II) bis(hexafluoridophosphate) acetonitrile solvate
por: Nag, Samik, et al.
Publicado: (2009) -
Photocytotoxic Activity of Ruthenium(II) Complexes with Phenanthroline-Hydrazone Ligands
por: Silva-Caldeira, Priscila Pereira, et al.
Publicado: (2021) -
cis-Bis(1,10-phenanthroline-κ(2)
N,N′)bis(pyridin-4-amine-κN
(1))ruthenium(II) bis(hexafluoridophosphate)
por: Camilo, Mariana R., et al.
Publicado: (2013)